AI-generated summary
The authors report a 16-week randomized trial in 150 people with Parkinson's disease comparing bright white light therapy given once daily, twice daily, or once weekly against dim red light controls. Twice-daily bright light showed the largest sleep score improvement, but the trial did not meet its prespecified threshold for advancing to a phase 3 study. Light therapy was reported as safe and well tolerated.
- Participants
- 150
- Who or what was studied
- People with Parkinson's disease who had impaired sleep (mean age 67 years, 38% female)
- Limits stated in the abstract
- The abstract does not report between-group differences with confidence intervals overlapping zero, and all sleep changes were analyzed relative to a sham comparison that did not reach the advancement threshold.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on movementdisorders.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Red light therapy, Dose, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.